Thursday, January 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

IBM Shares Gain as Jefferies Highlights Undervalued Software Potential

Felix Baarz by Felix Baarz
January 7, 2026
in Analysis, Tech & Software, Turnaround, Value & Growth
0
IBM Stock
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

A recent upgrade from Jefferies Financial Group has provided fresh momentum for International Business Machines Corp. (IBM), with the stock trading near its 52-week high. The firm’s analysts point to a significant re-rating opportunity within IBM’s software division, though traditional valuation metrics suggest investors should temper their enthusiasm.

Valuation Discount Presents Opportunity, Jefferies Argues

In a move that has captured market attention, Jefferies upgraded IBM from “Hold” to “Buy” on January 6. Analyst Brent Thill also raised the firm’s price target substantially, from $300 to $360 per share. This new target suggests an approximate 20% upside from the previous closing price of $302.23.

The core of Jefferies’ bullish thesis rests on an anticipated acceleration in IBM’s software revenue by 2026. The analysts highlight several key growth drivers they believe the market is undervaluing:
* Red Hat’s Momentum: Continued strength in the hybrid cloud platform segment.
* Strategic Acquisitions: Potential synergies from the integration of HashiCorp and the planned deal with Confluent.
* Stable Foundation: Reliable, recurring revenue from the legacy mainframe business.

A central argument for investment is IBM’s current valuation discount relative to large-cap software peers. Jefferies estimates a 2027 price-to-earnings (P/E) ratio of 26 for IBM, which sits below the sector average of approximately 35. This perspective has found some agreement elsewhere on Wall Street; RBC Capital increased its target to $350, while Stifel Nicolaus set a $325 target.

Should investors sell immediately? Or is it worth buying IBM?

Strong Operational Performance Fuels Confidence

The optimistic analyst outlook is supported by demonstrable operational strength. IBM’s recent extension of its partnership with The Wimbledon Championships as the official technology partner reinforces its competitive positioning in the enterprise AI solutions market.

The rally is fundamentally underpinned by robust third-quarter results. The company reported earnings per share of $2.65, surpassing estimates by $0.20. Year-over-year revenue climbed 9.1% to $16.33 billion. This solid operational execution has bolstered investor confidence, reflected in a share price gain of nearly 40% over the past twelve months.

Lofty Expectations Warrant Investor Caution

Despite the analyst enthusiasm, IBM’s shares are no longer trading at a bargain basement price. The stock currently commands a P/E ratio above 36. Furthermore, a price/earnings-to-growth (PEG) ratio of 2.70 indicates a rich valuation by historical standards, especially when compared to a lower industry average. Investors are presently paying a premium for expected future growth, which narrows the margin for error if performance disappoints.

The next critical test will arrive on January 28, 2026, when IBM discloses its full-year results. Market experts are forecasting annual earnings per share of $10.78. Whether the stock can achieve Jefferies’ elevated price target will depend heavily on the company’s ability to meet these high expectations.

Ad

IBM Stock: Buy or Sell?! New IBM Analysis from January 8 delivers the answer:

The latest IBM figures speak for themselves: Urgent action needed for IBM investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 8.

IBM: Buy or sell? Read more here...

Tags: IBM
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Barrick Stock
Analysis

Barrick Gold’s Strategic Pivot Faces Key Test with Upcoming Earnings

January 8, 2026
DroneShield Stock
Analysis

DroneShield Shares: Navigating High Hopes and Market Volatility

January 8, 2026
Aberdeen Global Income Stock
Analysis

Aberdeen Global Income Fund Faces Pivotal Vote as Merger Approaches

January 7, 2026
Next Post
Apex Critical Metals Stock

Apex Critical Metals Secures Key Permit, Paving Way for Drilling Campaign

MP Materials Stock

MP Materials Stock Surges on Unprecedented Trading Activity and Strategic Deals

Lynas Stock

Lynas Shares Rally on Geopolitical Tensions and Price Stabilization Hopes

Recommended

Aclaris Therapeutics Stock

Aclaris Therapeutics Stock: Poised for a Breakout Year?

2 months ago
Red Cat Holdings Stock

Red Cat Stock Soars on Multiple Growth Catalysts

3 months ago
Altus Power Stock

US Clean Energy Sector Braces for Consolidation Following Policy Shifts

3 months ago
Healthcare-and-IT

Changing Sentiment Towards UnitedHealth Group Stock

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Aberdeen Global Income Fund Faces Pivotal Vote as Merger Approaches

Alphabet’s AI Ambitions Fuel Market Momentum and Analyst Optimism

Insider Selling at Rocket Lab: A Sign of Caution or Routine Profit-Taking?

Uranium Energy Stock Receives Strong Endorsement Amid Sector Tailwinds

Nvidia’s Autonomous Driving Ambition Rattles Tesla Investors

Medical Properties Trust: A High-Stakes Options Play

Trending

Barrick Stock
Analysis

Barrick Gold’s Strategic Pivot Faces Key Test with Upcoming Earnings

by Robert Sasse
January 8, 2026
0

As Barrick Gold navigates a volatile precious metals landscape, the mining giant's strategic evolution will come under...

DroneShield Stock

DroneShield Shares: Navigating High Hopes and Market Volatility

January 8, 2026
Lynas Stock

Rare Earths Rally: Lynas Shares Surge on Supply Shock

January 8, 2026
Aberdeen Global Income Stock

Aberdeen Global Income Fund Faces Pivotal Vote as Merger Approaches

January 7, 2026
Alphabet Stock

Alphabet’s AI Ambitions Fuel Market Momentum and Analyst Optimism

January 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Barrick Gold’s Strategic Pivot Faces Key Test with Upcoming Earnings
  • DroneShield Shares: Navigating High Hopes and Market Volatility
  • Rare Earths Rally: Lynas Shares Surge on Supply Shock

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com